Aptevo Therapeutics Inc.APVONASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
5.71%
↑ 103% vs avg
Percentile
P54
Within normal range
Streak
2 qtr
Consecutive growthAccelerating
Average
-227.51%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 5.71% |
| Q2 2025 | -7.88% |
| Q1 2025 | -14.17% |
| Q4 2024 | -10.28% |
| Q3 2024 | 15.13% |
| Q2 2024 | 7.49% |
| Q1 2024 | -26.61% |
| Q4 2023 | 15.82% |
| Q3 2023 | -29.92% |
| Q2 2023 | -205.19% |
| Q1 2023 | 176.88% |
| Q4 2022 | 13.93% |
| Q3 2022 | -122.94% |
| Q2 2022 | 39.52% |
| Q1 2022 | -27.99% |
| Q4 2021 | 23.92% |
| Q3 2021 | 3.47% |
| Q2 2021 | 29.25% |
| Q1 2021 | -23.89% |
| Q4 2020 | 15.92% |
| Q3 2020 | -59.44% |
| Q2 2020 | 58.54% |
| Q1 2020 | -119.12% |
| Q4 2019 | 32.43% |
| Q3 2019 | 52.50% |
| Q2 2019 | -13.53% |
| Q1 2019 | -90.67% |
| Q4 2018 | 36.20% |
| Q3 2018 | 28.53% |
| Q2 2018 | 7.74% |
| Q1 2018 | -11.03% |
| Q4 2017 | -798.68% |
| Q3 2017 | 86.21% |
| Q2 2017 | 1.05% |
| Q1 2017 | -76.99% |
| Q4 2016 | -8131.82% |
| Q3 2016 | 99.48% |
| Q2 2016 | -11.02% |
| Q1 2016 | -85.19% |
| Q4 2015 | 16.28% |